ID: ALA3828143

Max Phase: Preclinical

Molecular Formula: C10H6BrN5

Molecular Weight: 276.10

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Brc1ccc(-c2ccnc3nnnn23)cc1

Standard InChI:  InChI=1S/C10H6BrN5/c11-8-3-1-7(2-4-8)9-5-6-12-10-13-14-15-16(9)10/h1-6H

Standard InChI Key:  FOEASMBZQRGRSU-UHFFFAOYSA-N

Associated Targets(Human)

Pancreatic alpha-amylase 74 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Alpha-glucosidase MAL12 70 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 276.10Molecular Weight (Monoisotopic): 274.9807AlogP: 1.95#Rotatable Bonds: 1
Polar Surface Area: 55.97Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 2.19CX LogD: 2.19
Aromatic Rings: 3Heavy Atoms: 16QED Weighted: 0.68Np Likeness Score: -2.09

References

1. Suresh L, Onkara P, Kumar PS, Pydisetty Y, Chandramouli GV..  (2016)  Ionic liquid-promoted multicomponent synthesis of fused tetrazolo[1,5-a]pyrimidines as α-glucosidase inhibitors.,  26  (16): [PMID:27406797] [10.1016/j.bmcl.2016.06.086]

Source